More than 200 people have participated in a day full of short talks, conferences, and networking activities.

A project to develop a compact, inexpensive and easy to use device for mass screening for malaria.

This collaboration solidifies their co-ownership of the patent application for "markers for the diagnosis of large vessel occlusion"

This investment from EIT Health in the project will enable D-Sight to progress in the clinical development of its groundbreaking treatment for the early stages of diabetic retinopathy.

One more year, we join the Movember movement to raise awareness of the need for research to improve men's health and, in particular, that of patients with prostate cancer.

The award recognizes people with an outstanding career for their relationship with the University and their social impact.

The course, directed by Dr. Jordi Riera, brought together around 30 teachers specialised in ECMO from different disciplines.

Dr. Conxita Jacobs' research has been awarded in the clinical project category, while Dr. Anna Meseguer's research has been recognised in the basic research category.

The list identifies the most influential experts, who are among the 1% most cited in their speciality in several areas of knowledge.

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

The award is a recognition for his significant contribution to the development of research in multiple sclerosis within the Catalan Institute of Health.

A study, led by Vall d'Hebron, identifies what type of information patients need to develop a web platform that will be useful to them when involving- se in making decisions about their treatment.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

After carrying out a first feasibility trial in collaboration with the Assisted Reproduction Section of the Vall d'Hebron Hospital, Manina Medtech is moving towards a pilot trial in IVF patients.

The evaluation committee has highlighted that VHIR has experienced a positive evolution in the last evaluation period.

The funds will enable the recruitment and retention of young talent, as well as the development of a new epigenetic drug

Researchers have used an innovative protocol to identify people with this autoimmune disease who have a higher risk of cancer.

As part of the initiative, WikiTropica, a tool that provides health professionals with up-to-date information on infectious and tropical diseases, has been launched.

This strategy protects almost two thirds of patients. It also reduces the waiting time between vaccination and initiation of immune suppressive treatment.

The aim is to make visible the attractiveness of VHIR as a place to work highlighting the unique opportunities it offers for biomedical research professionals at national and international level.

The initiative, coordinated by Dr. Pablo Velasco and Dr. Jose Luis Fuster, aims to bring innovation closer to patients and promote research projects in this disease.

This initiative of the ”la Caixa” Foundation offers the selected entrepreneurial scientists financial support and support through individual mentoring and training.

The project aims to test the HIPRA vaccine against COVID-19 in children (including adolescents) and immunocompromised people.

The European network EUPertStrain celebrates its annual meeting, focused on the study of the evolution of Bordetella pertussis, the bacterium responsible for this disease that can be very serious in children under one year.